|
|
| Key technologies used in protein expression studies include protein microarrays, a relatively new technique, and more established technologies such as 2D gel electrophoresis, liquid chromatography, mass spectrometry and flow cytometry. The market for each of these technologies is growing and the this report provides projections for just how much each segment of the protein expression market is expected to grow over the next few years.
The 2005 Protein Expression Analysis Report contains an overview of the protein expression market, the 2005 Protein Expression Analysis Survey, a thorough discussion of the survey results and final conclusions and recommendations. The 2005 Protein Expression Analysis Survey was completed by 480 researchers who are either currently performing (66%) or planning to perform (34%) protein expression analysis. The survey is intended to help suppliers gain a better understanding of which techniques their customers are using for protein expression studies, what types of samples they are using and how they are preparing them, which systems they plan to purchase, which companies they most frequently purchase from and the importance of analysis software packages in their research. Through the understanding of customer practices offered by the 2005 Protein Expression Analysis Survey, suppliers will be in a position to capitalize on the expanding, multi-billion dollar, protein expression analysis market. Survey Methodology The 2005 Protein Expression Analysis Survey consisted of 24 questions: 18 closed-ended and 6 open-ended. 9 of the closed-ended questions included “other” as an answer choice with space for survey participants to type in the answer most appropriate for their research. Demographic information was obtained from answers to 6 of the survey questions and from addresses submitted by survey participants. The survey was administered on-line between April 11th and 13th, 2005. |
Related Markets
Research & Development Reports
- Strategic Analysis of the U.S. Research Antibodies Market
- Biomarker and Diagnostic Opportunities in Respiratory Diseases
- Pharmacogenomic Partnering Terms and Agreements
- Advances in Peptide Therapeutics (Technical Insights)
- Innovative Technology Platforms: How They Are Paying Off for Big Pharma and Biotech
